Immune Modulation of Coronary Atherosclerosis With Anticytokine Treatment

scientific article published on 15 September 2020

Immune Modulation of Coronary Atherosclerosis With Anticytokine Treatment is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1161/CIRCIMAGING.120.011451
P932PMC publication ID7500823
P698PubMed publication ID32927972

P2093author name stringMohamed A Zayed
P2860cites workAtherosclerosis — An Inflammatory DiseaseQ26776972
Artery Tertiary Lymphoid Organs: Powerhouses of Atherosclerosis ImmunityQ28072367
Inflammation, atherosclerosis, and coronary artery diseaseQ29547232
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive proteinQ29547752
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystalsQ29615704
Quantitative Analysis of Lipid-Rich Necrotic Core in Carotid Atherosclerotic Plaques by In Vivo Magnetic Resonance Imaging and Clinical Outcomes.Q33797900
Anti-inflammatory therapies for cardiovascular diseaseQ34137872
Cytokines in atherosclerosis: pathogenic and regulatory pathwaysQ34511711
The autoimmune concept of atherosclerosisQ35550211
Cardiovascular co-morbidity in rheumatic diseasesQ36835851
The inextricable link between atherosclerosis and prototypical inflammatory diseases rheumatoid arthritis and systemic lupus erythematosusQ37206876
Adaptive immunity and atherosclerosisQ37563746
The discovery of cellular immunity in the atherosclerotic plaqueQ37619147
Anti-inflammatory therapeutics for the treatment of atherosclerosisQ37626768
Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT.Q38404769
Antiinflammatory Therapy with Canakinumab for Atherosclerotic DiseaseQ38606033
The Link Between Inflammatory Disorders and Coronary Heart Disease: a Look at Recent Studies and Novel Drugs in DevelopmentQ38688816
Dual-energy computed tomography imaging to determine atherosclerotic plaque composition: a prospective study with tissue validationQ41143090
C-reactive protein levels and outcomes after statin therapyQ45213511
Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies.Q46003173
New Insights into the Role of Inflammation in the Pathogenesis of Atherosclerosis.Q47148282
Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications.Q52312175
Atherosclerotic Heart Disease in Women With Autoimmune Rheumatologic Inflammatory Conditions.Q52344283
Inhibition of cholesterol atherosclerosis by immunisation with beta-lipoprotein.Q53741016
Prospective validation of standardized, 3-dimensional, quantitative coronary computed tomographic plaque measurements using radiofrequency backscatter intravascular ultrasound as reference standard in intermediate coronary arterial lesions: resultsQ83472030
IL-1 signalling in atherosclerosisQ91728284
Inflammation as a Therapeutic Target in AtherosclerosisQ92256742
Global Vascular Guidelines on the Management of Chronic Limb-Threatening IschemiaQ92640056
Low-Dose Methotrexate for the Prevention of Atherosclerotic EventsQ92980641
Treatment of Psoriasis With Biologic Therapy Is Associated With Improvement of Coronary Artery Plaque Lipid-Rich Necrotic Core: Results From a Prospective, Observational StudyQ99414622
P433issue9
P921main subjectcoronary artery diseaseQ844935
P304page(s)e011451
P577publication date2020-09-15
P1433published inCirculation: Cardiovascular ImagingQ3332375
P1476titleImmune Modulation of Coronary Atherosclerosis With Anticytokine Treatment
P478volume13

Search more.